BURGUNDY DIAMOND MINES LIMITED (BDM)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
BDM - BURGUNDY DIAMOND MINES LIMITED
FNArena Sector :
NONE
Year End: December
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.06
Index:
FNArena Sector : NONE
Year End: December
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.06
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.162
14 May |
0.002 OPEN $0.16 |
1.25% HIGH $0.17 |
599,921 LOW $0.16 |
TARGET | |||||
|
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY24 Forecast |
FY25 Forecast |
---|---|---|
EPS (cps) | 16.8 | xxx |
DPS (cps) | 0.0 | xxx |
EPS Growth | N/A | xxx |
DPS Growth | N/A | xxx |
PE Ratio | 1.0 | xxx |
Dividend Yield | 0.0% | xxx |
Div Pay Ratio(%) | N/A | xxx |
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.
All estimates have been converted into AUD by FNArena at present FX values.
DIVIDEND YIELD CALCULATOR
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -0.1 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 775.8 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 16.3 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 102.4 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -0.26 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -1.72 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -1.02 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -0.40 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -1.72 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 16.44 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 83.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 47 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 132 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 179 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 138 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.84 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 19.0 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 2.45 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 696 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 43 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 15 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
1.0
No. Of Recommendations
1
BDM STOCK CHART